MiR-409-3p inhibits HT1080 cell proliferation, vascularization and metastasis by targeting angiogenin

Cancer Letters

Volumn 323, Issue 2, 2012, Pages 171-179

  Weng, Chunhua ^a   Dong, Haojie ^a   Chen, Guangdi ^a   Zhai, Yixing ^a   Bai, Rongpan ^a   Hu, Hu ^a   Lu, Linrong ^a   Xu, Zhengping ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Angiogenin; Metastasis; MicroRNA; Tumorigenesis; Vascularization

Indexed keywords

ANGIOGENIN; MESSENGER RNA; MICRORNA; MICRORNA 409 3P; RIBOSOME RNA; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANGIOGENESIS; ANIMAL CELL; ANTIANGIOGENIC ACTIVITY; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; COMPUTER MODEL; CONTROLLED STUDY; CORRELATION ANALYSIS; DOWN REGULATION; FEMALE; FIBROSARCOMA; GENE MUTATION; GENE OVEREXPRESSION; GROWTH INHIBITION; HUMAN; HUMAN CELL; INHIBITION KINETICS; LUNG METASTASIS; METASTASIS INHIBITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN SYNTHESIS; PROTEIN TARGETING; RNA TRANSCRIPTION; STEADY STATE; TUMOR XENOGRAFT; UMBILICAL VEIN ENDOTHELIAL CELL;

3' UNTRANSLATED REGIONS; BASE SEQUENCE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA PRIMERS; HUMANS; IMMUNOHISTOCHEMISTRY; MICRORNAS; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; REAL-TIME POLYMERASE CHAIN REACTION; RIBONUCLEASE, PANCREATIC; RNA, RIBOSOMAL; TRANSCRIPTION, GENETIC;

EID: 84863110951     PISSN: 03043835     EISSN: 18727980     Source Type: Journal    
DOI: 10.1016/j.canlet.2012.04.010     Document Type: Article

References (40)

1. Fett J.W., Strydom D.J., Lobb R.R., Alderman E.M., Bethune J.L., Riordan J.F., Vallee B.L. Isolation and characterization of angiogenin, an angiogenic protein from human carcinoma cells. Biochemistry 1985, 24:5480-5486.
2. Gao X., Xu Z. Mechanisms of action of angiogenin. Acta Biochim. Biophys. Sin. (Shanghai) 2008, 40:619-624.
3. Kishimoto K., Liu S., Tsuji T., Olson K.A., Hu G.F. Endogenous angiogenin in endothelial cells is a general requirement for cell proliferation and angiogenesis. Oncogene 2005, 24:445-456.
4. Li S., Hu G.F. Angiogenin-mediated rRNA transcription in cancer and neurodegeneration. Int. J. Biochem. Mol. Biol. 2010, 1:26-35.
5. Tsuji T., Sun Y., Kishimoto K., Olson K.A., Liu S., Hirukawa S., Hu G.F. Angiogenin is translocated to the nucleus of HeLa cells and is involved in ribosomal RNA transcription and cell proliferation. Cancer Res. 2005, 65:1352-1360.
6. Yoshioka N., Wang L., Kishimoto K., Tsuji T., Hu G.F. A therapeutic target for prostate cancer based on angiogenin-stimulated angiogenesis and cancer cell proliferation. Proc. Natl. Acad. Sci. USA 2006, 103:14519-14524.
7. Ibaragi S., Yoshioka N., Li S., Hu M.G., Hirukawa S., Sadow P.M., Hu G.F. Neamine inhibits prostate cancer growth by suppressing angiogenin-mediated rRNA transcription. Clin. Cancer Res. 2009, 15:1981-1988.
8. Sadagopan S., Sharma-Walia N., Veettil M.V., Bottero V., Levine R., Vart R.J., Chandran B. Kaposi's sarcoma-associated herpesvirus upregulates angiogenin during infection of human dermal microvascular endothelial cells, which induces 45S rRNA synthesis, antiapoptosis, cell proliferation, migration, and angiogenesis. J. Virol. 2009, 83:3342-3364.
9. Yuan Y., Wang F., Liu X.H., Gong D.J., Cheng H.Z., Huang S.D. Angiogenin is involved in lung adenocarcinoma cell proliferation and angiogenesis. Lung Cancer 2009, 66:28-36.
10. Bartel D.P. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004, 116:281-297.
11. Fish J.E., Srivastava D. MicroRNAs: opening a new vein in angiogenesis research. Sci. Signal 2009, 2:Pe1.
12. Negrini M., Nicoloso M.S., Calin G.A. MicroRNAs and cancer-new paradigms in molecular oncology. Curr. Opin. Cell Biol. 2009, 21:470-479.
13. Liu S., Yu D., Xu Z.P., Riordan J.F., Hu G.F. Angiogenin activates Erk1/2 in human umbilical vein endothelial cells. Biochem. Biophys. Res. Commun. 2001, 287:305-310.
14. Xu Z.P., Tsuji T., Riordan J.F., Hu G.F. The nuclear function of angiogenin in endothelial cells is related to rRNA production. Biochem. Biophys. Res. Commun. 2002, 294:287-292.
15. Ibaragi S., Yoshioka N., Kishikawa H., Hu J.K., Sadow P.M., Li M., Hu G.F. Angiogenin-stimulated rRNA transcription is essential for initiation and survival of AKT-induced prostate intraepithelial neoplasia. Mol. Cancer Res. 2009, 7:415-424.
16. Hillen F., Griffioen A.W. Tumour vascularization: sprouting angiogenesis and beyond. Cancer Metastasis Rev. 2007, 26:489-502.
17. Maniotis A.J., Folberg R., Hess A., Seftor E.A., Gardner L.M., Pe'er J., Trent J.M., Meltzer P.S., Hendrix M.J. Vascular channel formation by human melanoma cells in vivo and in vitro: vasculogenic mimicry. Am. J. Pathol. 1999, 155:739-752.
18. Kleinman H.K., Martin G.R. Matrigel: basement membrane matrix with biological activity. Semin. Cancer Biol. 2005, 15:378-386.
19. Fujimoto A., Onodera H., Mori A., Isobe N., Yasuda S., Oe H., Yonenaga Y., Tachibana T., Imamura M. Vascular endothelial growth factor reduces mural cell coverage of endothelial cells and induces sprouting rather than luminal division in an HT1080 tumour angiogenesis model. Int. J. Exp. Pathol. 2004, 85:355-364.
20. Tello-Montoliu A., Patel J.V., Lip G.Y. Angiogenin: a review of the pathophysiology and potential clinical applications. J. Thromb. Haemost. 2006, 4:1864-1874.
21. Hartmann A., Kunz M., Kostlin S., Gillitzer R., Toksoy A., Brocker E.B., Klein C.E. Hypoxia-induced up-regulation of angiogenin in human malignant melanoma. Cancer Res. 1999, 59:1578-1583.
22. Nilsson U.W., Abrahamsson A., Dabrosin C. Angiogenin regulation by estradiol in breast tissue: tamoxifen inhibits angiogenin nuclear translocation and antiangiogenin therapy reduces breast cancer growth in vivo. Clin. Cancer Res. 2010, 16:3659-3669.
23. Campo L., Turley H., Han C., Pezzella F., Gatter K.C., Harris A.L., Fox S.B. Angiogenin is up-regulated in the nucleus and cytoplasm in human primary breast carcinoma and is associated with markers of hypoxia but not survival. J. Pathol. 2005, 205:585-591.
24. Fort A., Borel C., Migliavacca E., Antonarakis S.E., Fish R.J., Neerman-Arbez M. Regulation of fibrinogen production by microRNAs. Blood 2010, 116:2608-2615.
25. Staton C.A., Brown N.J., Lewis C.E. The role of fibrinogen and related fragments in tumour angiogenesis and metastasis. Expert Opin. Biol. Ther. 2003, 3:1105-1120.
26. Zheng B., Liang L., Huang S., Zha R., Liu L., Jia D., Tian Q., Wang Q., Wang C., Long Z., Zhou Y., Cao X., Du C., Shi Y., He X. MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Oncogene 2011, Epub ahead of print.
27. Liu G., Voyno-Yasenetskaya T.A. Radixin stimulates Rac1 and Ca2+/calmodulin-dependent kinase, CaMKII: cross-talk with Galpha13 signaling. J. Biol. Chem. 2005, 280:39042-39049.
28. Hoeflich K.P., Ikura M. Radixin: cytoskeletal adopter and signaling protein. Int. J. Biochem. Cell Biol. 2004, 36:2131-2136.
29. Arpin M., Chirivino D., Naba A., Zwaenepoel I. Emerging role for ERM proteins in cell adhesion and migration. Cell Adh Migr 2011, 5:199-206.
30. Wei M., Liu B., Su L., Li J., Zhang J., Yu Y., Yan M., Yang Z., Chen X., Liu J., Lv X., Nie H., Zhang Q., Zheng Z., Yu B., Ji J., Zhu Z., Gu Q. A novel plant homeodomain finger 10-mediated antiapoptotic mechanism involving repression of caspase-3 in gastric cancer cells. Mol. Cancer Ther. 2010, 9:1764-1774.
31. Li C., Nie H., Wang M., Su L., Li J., Yu B., Wei M., Ju J., Yu Y., Yan M., Gu Q., Zhu Z., Liu B. MicroRNA-409-3p regulates cell proliferation and apoptosis by targeting PHF10 in gastric cancer. Cancer Lett. 2012, (Epub ahead of print).
32. Mestdagh P., Lefever S., Pattyn F., Ridzon D., Fredlund E., Fieuw A., Ongenaert M., Vermeulen J., De Paepe A., Wong L., Speleman F., Chen C., Vandesompele J. The microRNA body map: dissecting microRNA function through integrative genomics. Nucleic Acids Res. 2011, 39:e136.
33. Bissell M.J. Tumor plasticity allows vasculogenic mimicry, a novel form of angiogenic switch. A rose by any other name?. Am. J. Pathol. 1999, 155:675-679.
34. Ugurel S., Rappl G., Tilgen W., Reinhold U. Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival. J. Clin. Oncol. 2001, 19:577-583.
35. Olson K.A., Byers H.R., Key M.E., Fett J.W. Prevention of human prostate tumor metastasis in athymic mice by antisense targeting of human angiogenin. Clin. Cancer Res. 2001, 7:3598-3605.
36. Olson K.A., French T.C., Vallee B.L., Fett J.W. A monoclonal antibody to human angiogenin suppresses tumor growth in athymic mice. Cancer Res. 1994, 54:4576-4579.
37. Olson K.A., Byers H.R., Key M.E., Fett J.W. Inhibition of prostate carcinoma establishment and metastatic growth in mice by an antiangiogenin monoclonal antibody. Int. J. Cancer 2002, 98:923-929.
38. Olson K.A., Fett J.W., French T.C., Key M.E., Vallee B.L. Angiogenin antagonists prevent tumor growth in vivo. Proc. Natl. Acad. Sci. USA 1995, 92:442-446.
39. Schwartz B., Shoseyov O., Melnikova V.O., McCarty M., Leslie M., Roiz L., Smirnoff P., Hu G.F., Lev D., Bar-Eli M. ACTIBIND, a T2 RNase, competes with angiogenin and inhibits human melanoma growth, angiogenesis, and metastasis. Cancer Res. 2007, 67:5258-5266.
40. Hirukawa S., Olson K.A., Tsuji T., Hu G.F. Neamine inhibits xenografic human tumor growth and angiogenesis in athymic mice. Clin. Cancer Res. 2005, 11:8745-8752.